Riskpilot← Back to searchSign inGet full accessFarum Dyreklinik ApS
APSActiveCVR 28693826Farum Hovedgade 40BVeterinary activities · NACE 7500Est. 200517 employeeswww.farumdyreklinik.dk
Revenue 2025
DKK 6,6M
+23% vs 2024
EBITDA margin
21.8%
+292% vs 2024
Equity ratio
18.2%
Financial strength
Net profit 2025
DKK 1,2M
+298% vs 2024
| Revenue | DKK 6,6M | +23% |
| EBITDA | DKK 1,4M | +292% |
| Net profit | DKK 1,2M | +298% |
| Total assets | DKK 4,8M | +14% |
| Equity | DKK 866K | +404% |
| Employees | 17 | — |
Legal name
Farum Dyreklinik ApS
CVR number
28693826
Legal form
Anpartsselskab
NACE code
7500 · Veterinary activities
Founded
28. april 2005
Share capital
DKK 50.000
Employees
17 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2025-04-30
Financial year
January – December
Signatory rights
Selskabet tegnes af direktionen.
Company purpose
Selskabets formål er at udøve dyrlægevirksomhed, herunder sundhedspleje af husdyr og kæledyr, samt dermed beslægtet virksomhed.
Address
Farum Hovedgade 40B
Phone
+4544950388
Email
fd@farumdyreklinik.dk
Website
www.farumdyreklinik.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | -14 | -13 | -10 | -15 | -12 | -17 | 335 | 369 | 348 | 268 | -51 | -24 | 5.409 | 6.633 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -247 | -323 | -421 | -311 | -1 | -0 | -5.006 | -5.188 |
| EBITDA | -14 | 7 | -10 | -15 | -12 | -17 | 88 | 46 | -73 | -43 | -52 | -59 | 368 | 1.445 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -359 | -522 |
| EBIT | -14 | 7 | -10 | -15 | -12 | -17 | 88 | 46 | -73 | -43 | -52 | -59 | 10 | 923 |
| Net financials | -1.109 | 37 | 22 | 22 | 22 | 16 | -0 | 0 | -0 | -73 | -74 | -125 | -370 | 110 |
| Profit before tax | -1.123 | 44 | 11 | 7 | 10 | -1 | 88 | 46 | -73 | -116 | -127 | -185 | -360 | 1.033 |
| Tax | 18 | 10 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -550 | -0 | 220 | -117 |
| Net profit | -1.141 | 34 | 11 | 7 | 10 | -1 | 88 | 46 | -73 | -116 | 423 | -185 | -580 | 1.150 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 5.759 | 561 | 555 | 564 | 574 | 122 | 254 | 305 | 197 | 1.301 | 2.451 | 2.826 | 4.175 | 4.757 |
| Equity | 500 | 534 | 545 | 552 | 562 | 111 | 199 | 246 | 173 | 57 | 480 | 296 | -285 | 866 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 5.259 | 28 | 10 | 13 | 13 | 11 | 55 | 60 | 24 | 1.244 | 1.970 | 2.530 | 4.460 | 3.892 |
| Total debt | 5.259 | 28 | 10 | 13 | 13 | 11 | 55 | 60 | 24 | 1.244 | 1.970 | 2.530 | 4.460 | 3.892 |
EBITDA margin
21.8%
This company
15.8%
Market median
+38% vs market
20122025
Equity ratio
18.2%
This company
38.2%
Market median
-52% vs market
20122025
Return on equity
132.9%
This company
18.4%
Market median
+622% vs market
20122025
Net profit margin
17.3%
This company
8.1%
Market median
+114% vs market
20122025
Asset turnover
1.39×
This company
1.12×
Market median
+24% vs market
20122025
Debt / equity
4.50×
This company
0.62×
Market median
-626% vs market
20122025
- Annual report 2025Filed via CVR / Virk · Period 2024-05-01 – 2025-04-30
- Annual report 2024Filed via CVR / Virk · Period 2023-05-01 – 2024-04-30
- Annual report 2023Filed via CVR / Virk · Period 2022-05-01 – 2023-04-30
- Annual report 2022Filed via CVR / Virk · Period 2021-05-01 – 2022-04-30
- Annual report 2021Filed via CVR / Virk · Period 2020-05-01 – 2021-04-30
- Annual report 2020Filed via CVR / Virk · Period 2019-05-01 – 2020-04-30
- Annual report 2019Filed via CVR / Virk · Period 2018-05-01 – 2019-04-30
- Annual report 2018Filed via CVR / Virk · Period 2017-05-01 – 2018-04-30
- Annual report 2017Filed via CVR / Virk · Period 2016-05-01 – 2017-04-30
- Annual report 2016Filed via CVR / Virk · Period 2015-05-01 – 2016-04-30
- Annual report 2015Filed via CVR / Virk · Period 2014-05-01 – 2015-04-30
- Annual report 2014Filed via CVR / Virk · Period 2013-05-01 – 2014-04-30
- Annual report 2013Filed via CVR / Virk · Period 2012-05-01 – 2013-04-30
- Annual report 2012Filed via CVR / Virk · Period 2011-05-01 – 2012-04-30
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
MN Chief Executive Officer | Chief Executive Officer | 2008 | — | — |
NC Management | Management | 2016 | — | — |
SV Chief Executive Officer | Chief Executive Officer | 2008 | — | — |
PK Management | Management | 2005 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2005 | — | — | |
| Chairman | 2008 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
NCV INVEST ApS | Company | 100.0% | 100.0% | 2017 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
NCV INVEST ApS
Farum Dyreklinik ApS Board members of Farum Dyreklinik ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Mette Nør Mønsted | Chief Executive Officer | 0 companies |
| Ninna Christine Verland | Management | 0 companies |
| Sten Verland | Chief Executive Officer | 0 companies |
| Per Kjeld Mønsted | Management | 0 companies |
| Erik Bo Lindblad | Board of Directors | 0 companies |
| Louise Martine Vilhelm Verland | Chairman | 0 companies |